Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268

Gut microbiota composition correlates with diet and health in the elderly

Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314

The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.

(2015) · PubMed Central · Cited by 2,540

n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases

Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518

Short-chain fatty acids in control of body weight and insulin sensitivity

Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067

Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans

Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., González, A., Fontana, L., Henrissat, B., Knight, R., & Gordon, J. I. (2011) · Science · doi:10.1126/science.1198719 · Cited by 1,988

The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice

Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748

Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow

Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,462

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426

Microbes in Gastrointestinal Health and Disease

Neish, A. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,423

How informative is the mouse for human gut microbiota research?

Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334

Gut immune maturation depends on colonization with a host-specific microbiota

Chung, H., Pamp, S. J., Hill, J. A., Surana, N. K., Edelman, S. M., Troy, E. B., Reading, N. C., Villablanca, E. J., Wang, S., Mora, J. R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.037 · Cited by 1,241

Consumption of fermented milk product with probiotic modulates brain activity

Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192

Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation

Hemarajata, P., & Versalovic, J. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12459294 · Cited by 1,083

Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice

Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076

The influence of diet on the gut microbiota

Scott, K. P., Gratz, S. W., Sheridan, P. O., Flint, H. J., & Duncan, S. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.020 · Cited by 1,052

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H. J., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,044

Microbiota and diabetes: an evolving relationship

Tilg, H., & Moschen, A. R. (2014) · Gut · doi:10.1136/gutjnl-2014-306928 · Cited by 853

LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms

Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828

The role of microbiome in central nervous system disorders

Wang, Y., & Kasper, L. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.015 · Cited by 803

Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation

Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750

The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases

Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731

Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota

Lee, H. C., Jenner, A. M., Low, C. S., & Lee, Y. K. (2006) · Research in Microbiology · doi:10.1016/j.resmic.2006.07.004 · Cited by 697

Interactions of gut microbiota with functional food components and nutraceuticals

Laparra, J. M., & Sanz, Y. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.001 · Cited by 684

The Gut Microbiome and the Brain

Galland, L. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.7000 · Cited by 648

Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis

Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12109 · Cited by 637

Review article: dietary fibre-microbiota interactions

Simpson, H. L., & Campbell, B. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13248 · Cited by 602

The gut microbiota, obesity and insulin resistance

Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592

Antibiotics, Pediatric Dysbiosis, and Disease

Vangay, P., Ward, T., Gerber, J. S., & Knights, D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.006 · Cited by 556

Infant antibiotic exposures and early-life body mass

Trasande, L., Blustein, J., Liu, M., Corwin, E. J., Cox, L. M., & Blaser, M. J. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.132 · Cited by 514

A Unifying Role for Prions in Neurodegenerative Diseases

Prusiner, S. B. (2012) · Science · doi:10.1126/science.1222951 · Cited by 507

Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019

Gill, H. S., Rutherfurd, K. J., Cross, M. L., & Gopal, P. K. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.833 · Cited by 485

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 472

Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases

Calder, P. C. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700289 · Cited by 465

The dormant blood microbiome in chronic, inflammatory diseases

Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 384

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

Ferreira, S. T., Clarke, J. R., Bomfim, T. R., & Felice, F. G. D. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.010 · Cited by 363

Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer's disease

Park, J., Lee, B. K., Jeong, G. S., Hyun, J. K., Lee, C. J., & Lee, S. (2014) · Lab on a Chip · doi:10.1039/c4lc00962b · Cited by 363

Neurodegenerative Diseases: Expanding the Prion Concept

Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361

Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration

Friedland, R. P. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142841 · Cited by 338

Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease

Pablo, J. P., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01150.x · Cited by 333

Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice

Carvalho, B. M., Guadagnini, D., Tsukumo, D. M. L., Schenka, A. A., Latuf-Filho, P., Vassallo, J., Dias, J. C., Kubota, L. T., Carvalheira, J. B. C., & Saad, M. J. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2648-4 · Cited by 324

Diversity, biogenesis and function of microbial amyloids

Blanco, L. P., Evans, M. L., Smith, D. R., Badtke, M. P., & Chapman, M. R. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.005 · Cited by 320

Age-Associated Remodeling of the Intestinal Epithelial Barrier

Tran, L., & Greenwood-Van Meerveld, B. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt106 · Cited by 320

The Role of Lipocalin 2 in the Regulation of Inflammation in Adipocytes and Macrophages

Zhang, J., Wu, Y., Zhang, Y., LeRoith, D., Bernlohr, D., & Chen, X. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0420 · Cited by 302

Microbiota regulation of the mammalian gut-brain axis

Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300

A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer's Disease

Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288

Blood–brain-barriers in aging and in Alzheimer’s disease

Marques, F., Sousa, J. C., Sousa, N., & Palha, J. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-38 · Cited by 285

Neuroprotective effects of green and black teas and their catechin gallate esters against β‐amyloid‐induced toxicity

Bastianetto, S., Yao, Z., Papadopoulos, V., & Quirion, R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04532.x · Cited by 283

Gut microbiota and gastrointestinal health: current concepts and future directions

Aziz, Q., Doré, J., Emmanuel, A., Guarner, F., & Quigley, E. M. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12046 · Cited by 280

Gut microorganisms as promising targets for the management of type 2 diabetes

Delzenne, N. M., Cani, P. D., Everard, A., Neyrinck, A. M., & Bindels, L. B. (2015) · Diabetologia · doi:10.1007/s00125-015-3712-7 · Cited by 271

Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 267

Olive-Oil-Derived Oleocanthal Enhances β-Amyloid Clearance as a Potential Neuroprotective Mechanism against Alzheimer’s Disease: In Vitro and in Vivo Studies

Abuznait, A. H., Qosa, H., Busnena, B. A., Sayed, K. A. E., & Kaddoumi, A. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400024q · Cited by 266

Alzheimer's disease and the microbiome

Bhattacharjee, S., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00153 · Cited by 253

The Microbiome and Disease: Reviewing the Links between the Oral Microbiome, Aging, and Alzheimer's Disease

Shoemark, D. K., & Allen, S. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141170 · Cited by 251

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection

Stecher, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0008-2014 · Cited by 250

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

(2012) · PubMed Central · Cited by 248

U.S. Outpatient Antibiotic Prescribing, 2010

Hicks, L. A., Taylor, T. H., & Hunkler, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212055 · Cited by 247

Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

Zhang, J., Ke, K., Liu, Z., Qiu, Y., & Peng, Y.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075786 · Cited by 243

Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome

Delzenne, N. M., Neyrinck, A. M., & Cani, P. D. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s10 · Cited by 241

New Technologies for Studying Biofilms

Franklin, M. J., Chang, C. B., Akiyama, T., & Bothner, B. B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0016-2014 · Cited by 238

Microbiota and the gut–brain axis

Bienenstock, J., Kunze, W., & Forsythe, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv019 · Cited by 234

Microbiome disturbances and autism spectrum disorders

Rosenfeld, C. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063826 · Cited by 229

Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases

Morales, R., Moreno‐González, I., & Soto, C. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003537 · Cited by 225

The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial

Wang, I. ‐., Wu, Y. Y., Yang, Y., Ting, I., Lin, C. C., Yen, T., Chen, J.-H., Wang, C., Huang, C.-F., & Lin, H. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0088 · Cited by 223

Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation

Kim, M., Hwang, S., Park, E., & Bae, J. (2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12079 · Cited by 220

Widespread Expression of Serum Amyloid A in Histologically Normal Human Tissues: Predominant Localization to the Epithelium

Urieli-Shoval, S., Cohen, P., Eisenberg, S., & Matzner, Y. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804601206 · Cited by 219

Transmissible Proteins: Expanding the Prion Heresy

Soto, C. A. (2012) · Cell · doi:10.1016/j.cell.2012.05.007 · Cited by 215

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action

Fernando, W. M. A. D. B., Martins, I. J., Goozee, K. G., Brennan, C. S., Jayasena, V., & Martins, R. N. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001452 · Cited by 200

Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study

John, S., Luben, R., Shrestha, S. S., Welch, A. A., Khaw, K., & Hart, A. R. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283352d05 · Cited by 184

The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

Hultman, K., Strickland, S., & Norris, E. H. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.76 · Cited by 183

Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?

Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180

Dietary Fructans, but Not Cellulose, Decrease Triglyceride Accumulation in the Liver of Obese Zucker fa/fa Rats

Daubioul, C., Rousseau, N., Taper, H. S., Declerck, B., Delzenne, N. M., Demeure, R., & Gallez, B. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.967 · Cited by 178

Microbial amyloids – functions and interactions within the host

Schwartz, K., & Boles, B. R. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.12.001 · Cited by 177

Microbial-generated amyloids and Alzheimer's disease (AD)

Hill, J. M., & Lukiw, W. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00009 · Cited by 173

Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut

Rhee, S. H. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.2.90 · Cited by 171

Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease

Paula‐Lima, A. C., Brito‐Moreira, J., & Ferreira, S. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12304 · Cited by 170

Higher normal fasting plasma glucose is associated with hippocampal atrophy

Cherbuin, N., Sachdev, P. S., & Anstey, K. J. (2012) · Neurology · doi:10.1212/wnl.0b013e31826846de · Cited by 170

Impaired glycemia increases disease progression in mild cognitive impairment

Morris, J. K., Vidoni, E. D., Honea, R. A., & Burns, J. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.033 · Cited by 163

NMDA Receptor Activity in Neuropsychiatric Disorders

Lakhan, S. E., Caro, M. A., & Hadzimichalis, N. M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00052 · Cited by 160

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals

Berti, V., Murray, J., Davies, M., Spector, N. C., Tsui, W. H., Li, Y., Williams, S. K., Pirraglia, E., Vallabhajosula, S., McHugh, P. F., et al. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0534-0 · Cited by 156

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial

Tomasik, J., Yolken, R. H., Bahn, S., & Dickerson, F. (2015) · Biomarker Insights · doi:10.4137/bmi.s22007 · Cited by 155

Cardiovascular Risk Factors for Alzheimer's Disease

Rosendorff, C., Beeri, M. S., & Silverman, J. M. (2007) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2007.06696.x · Cited by 154

Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).

Zhao, Y., & Lukiw, W. J. (2015) · PubMed · Cited by 149

Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling

Qosa, H., Abuasal, B. S., Romero, I. A., Weksler, B., Couraud, P.-O., Keller, J. N., & Kaddoumi, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.023 · Cited by 146

The effects of gut microbiota on CNS function in humans

Tillisch, K. (2014) · Gut Microbes · doi:10.4161/gmic.29232 · Cited by 144

Functional amyloid formation by Streptococcus mutans

Oli, M. W., Otoo, H. N., Crowley, P. J., Heim, K. P., Nascimento, M. M., Ramsook, C. B., Lipke, P. N., & Brady, L. J. (2012) · Microbiology · doi:10.1099/mic.0.060855-0 · Cited by 144

Chronic Functional Bowel Syndrome Enhances Gut-Brain Axis Dysfunction, Neuroinflammation, Cognitive Impairment, and Vulnerability to Dementia

Daulatzai, M. A. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1266-6 · Cited by 143

Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)

P, Z. Y. D. (2015) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000177 · Cited by 141

Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier

Zloković, B. V. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00310-4 · Cited by 139

Altered synapses and gliotransmission in Alzheimer's disease and AD model mice

Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138

The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness

Hornig, M. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32836208de · Cited by 138

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Esteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133

Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils

Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., & Bieschke, J. (2011) · Biochemistry · doi:10.1021/bi2012383 · Cited by 133

Amyloidogenic potential of foie gras

Solomon, A., Richey, T., Murphy, C. L., Weiss, D. T., Wall, J. S., Westermark, G. T., & Westermark, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700848104 · Cited by 132

Induction of Bacterial Antigen-Specific Colitis by a Simplified Human Microbiota Consortium in Gnotobiotic Interleukin-10 −/− Mice

Eun, C. S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I. M., & Sartor, R. B. (2014) · Infection and Immunity · doi:10.1128/iai.01513-13 · Cited by 128

An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases

Lorente‐Cebrián, S., Costa, A. G. V., Navas‐Carretero, S., Zabala, M., Laiglesia, L. M., Martínez, J. A., & Moreno-Aliaga, M. J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0395-y · Cited by 124

Probiotics, prebiotics, and the host microbiome: the science of translation

Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., Cani, P. D., Degnan, F. H., Foster, J., Gibson, G., et al. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12303 · Cited by 124

Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation.

Liu, Y.-Q., Pukala, T., Musgrave, I., Williams, D. M., Dehle, F., & Carver, J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.071 · Cited by 121

α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation

Wang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 119

Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?

Carlino, D., Vanna, M. D., & Tongiorgi, E. (2012) · The Neuroscientist · doi:10.1177/1073858412469444 · Cited by 117

Elucidating the Mechanism of Lipid Membrane-Induced IAPP Fibrillogenesis and Its Inhibition by the Red Wine Compound Resveratrol: A Synchrotron X-ray Reflectivity Study

Platten, F., Jeworrek, C., Tiemeyer, S., Weise, K., Sellin, D., Paulus, M., Struth, B., Tolan, M., & Winter, R. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8097417 · Cited by 114

The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies

Cheng, L., Quek, C. Y. J., Sun, X., Bellingham, S. A., & Hill, A. F. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00150 · Cited by 113

Disease to Dirt: The Biology of Microbial Amyloids

Hufnagel, D. A., Tükel, Ç., & Chapman, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003740 · Cited by 113

Will caloric restriction and folate protect against AD and PD?

Mattson, M. P. (2003) · Neurology · doi:10.1212/01.wnl.0000042785.02850.11 · Cited by 111

Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.

Zamolodchikov, D., & Strickland, S. (2012) · Blood · doi:10.1182/blood-2011-11-389668 · Cited by 109

Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease

Naseer, M. I., Bibi, F., Al-Qahtani, M. H., Chaudhary, A., Azhar, E. I., Kamal, M. A., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109

Prions and the Potential Transmissibility of Protein Misfolding Diseases

Kraus, A., Groveman, B. R., & Caughey, B. W. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155735 · Cited by 107

Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation

Stefani, M., & Rigacci, S. (2014) · BioFactors · doi:10.1002/biof.1171 · Cited by 106

Amyloids: Friend or Foe?

Hammer, N. D., Wang, X., McGuffie, B. A., & Chapman, M. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13406 · Cited by 96

Humans Have Antibodies against a Plant Virus: Evidence from Tobacco Mosaic Virus

Liu, R., Vaishnav, R., Roberts, A. M., & Friedland, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060621 · Cited by 95

The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA

Colussi, T. M., Costantino, D. A., Hammond, J. A., Ruehle, G. M., Nix, J. C., & Kieft, J. S. (2014) · Nature · doi:10.1038/nature13378 · Cited by 91

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study

Mosconi, L., Murray, J., Davies, M., Williams, S., Pirraglia, E., Spector, N. C., Tsui, W. H., Li, Y., Butler, T., Osorio, R. S., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004850 · Cited by 89

The role of lipopolysaccharide‐binding protein in innate immunity: a revisit and its relevance to oral/periodontal health

Ding, P., & Jin, L. (2013) · Journal of Periodontal Research · doi:10.1111/jre.12081 · Cited by 85

Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease

Rigacci, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_1 · Cited by 84

Shared genetic etiology underlying Alzheimer’s disease and type 2 diabetes

Hao, K., Di Narzo, A. F., Ho, L., Luo, W., Li, S., Chen, R., Li, T., Dubner, L., & Pasinetti, G. M. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.06.006 · Cited by 84

Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain

Liang, J.-S., Sloane, J. A., Wells, J. M., Abraham, C. R., Fine, R. E., & Sipe, J. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00196-1 · Cited by 84

Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan

Lai, S., Liao, K., Lin, C., & Sung, F. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9878-3 · Cited by 84

Understanding gut microbiota in elderly's health will enable intervention through probiotics

Pérez‐Martínez, G., Bäuerl, C., & Collado, M. C. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0079 · Cited by 82

Polyphenols as Potential Inhibitors of Amyloid Aggregation and Toxicity:Possible Significance to Alzheimers Disease

Bastianetto, S., Krantic, S., & Quirion, R. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708784223512 · Cited by 81

The various states of von Willebrand factor and their function in physiology and pathophysiology

Huck, V., Gorzelanny, C., Schneider, M. F., & Schneider, S. W. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0800 · Cited by 81

Oral Delivery of Bioencapsulated Proteins Across Blood–Brain and Blood–Retinal Barriers

Kohli, N., Westerveld, D., Ayache, A., Verma, A., Shil, P. K., Prasad, T., Zhu, P., Chan, S. L., Li, Q., & Daniell, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.273 · Cited by 81

Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia

Daulatzai, M. A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150202152436 · Cited by 80

The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes

Bekkering, P., Jafri, I., van Overveld, F. J., & Rijkers, G. T. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.848793 · Cited by 78

Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

Rincón, D., Vaquero, J., Hernando, A., Galindo, E., Ripoll, C., Puerto, M., Salcedo, M., Francés, R., Matilla, A. M., Catalina, M., et al. (2014) · Liver International · doi:10.1111/liv.12539 · Cited by 76

Microfluidic construction of minimalistic neuronal co-cultures

Dinh, N., Chiang, Y.-Y., Hardelauf, H., Baumann, J., Jackson, E., Waide, S., Sisnaiske, J., Frimat, J., van Thriel, C., Janasek, D., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc41224e · Cited by 76

Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes

Viegas, P., Chaverot, N., Enslen, H., Perrière, N., Couraud, P., & Cazaubon, S. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03222 · Cited by 73

Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases

Pistollato, F., & Battino, M. A. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.07.012 · Cited by 73

Walnut Extract Inhibits the Fibrillization of Amyloid Beta-Protein, and also Defibrillizes its Preformed Fibrils

Chauhan, N., Wang, K., Węgiel, J., & Malik, M. N. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332144 · Cited by 71

Garlic extract exhibits antiamyloidogenic activity on amyloid‐beta fibrillogenesis: relevance to Alzheimer's disease

Gupta, V. B., Indi, S. S., & Rao, K. S. J. (2008) · Phytotherapy Research · doi:10.1002/ptr.2574 · Cited by 70

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols

Rigacci, S., & Stefani, M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.986101 · Cited by 69

Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease

Kenna, H. A., Hoeft, F., Kelley, R. G., Wroolie, T., DeMuth, B. N., Reiss, A. L., & Rasgon, N. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.006 · Cited by 69

Autoimmunity and the Gut

Campbell, A. W. (2014) · Autoimmune Diseases · doi:10.1155/2014/152428 · Cited by 67

Role of the Gut Microbiota in Age-Related Chronic Inflammation

Rehman, T. (2012) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/187153012803832620 · Cited by 67

Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol

Björklund, M., Ouwehand, A. C., Forssten, S. D., Nikkilä, J., Tiihonen, K., Rautonen, N., & Lahtinen, S. J. (2012) · AGE · doi:10.1007/s11357-011-9294-5 · Cited by 67

Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer′s disease

Essa, M. M., Braidy, N., Awlad-Thani, K., Vaishnav, R., Al-Asmi, A. R., Guillemin, G. J., Al‐Adawi, S., & Subash, S. (2015) · Journal of Ayurveda and Integrative Medicine · doi:10.4103/0975-9476.159073 · Cited by 67

Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma‐Pi 2 diet

Fallucca, F., Porrata, C., Fallucca, S., & Pianesi, M. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2518 · Cited by 66

Fold modulating function: bacterial toxins to functional amyloids

Syed, A. K., & Boles, B. R. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00401 · Cited by 65

The importance of fish and docosahexaenoic acid in Alzheimer disease

Connor, W. E., & Connor, S. L. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.4.929 · Cited by 61

Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease

Álvarez, A., Aleixandre, M., Linares, C., Masliah, E., & Moessler, H. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140849 · Cited by 61

Chemoprevention in Gastrointestinal Physiology and Disease. Natural products and microbiome

Greiner, A. K., Papineni, R. V. L., & Umar, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2014 · Cited by 60

Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines

Hügel, H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_5 · Cited by 57

Resveratrol interferes with the aggregation of membrane-bound human-IAPP: A molecular dynamics study

Lolicato, F., Raudino, A., Milardi, D., & Rosa, C. L. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.047 · Cited by 55

The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review

Blom, K., Emmelot‐Vonk, M. H., & Koek, H. L. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.06.011 · Cited by 54

Obesity—a disease with many aetiologies disguised in the same oversized phenotype: has the overeating theory failed?

Stenvinkel, P. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu338 · Cited by 54

TREM2 and Risk of Alzheimer’s Disease — Friend or Foe?

Tanzi, R. E. (2015) · New England Journal of Medicine · doi:10.1056/nejmcibr1503954 · Cited by 52

How free of germs is germ-free? Detection of bacterial contamination in a germ free mouse unit

Fontaine, C., Skorupski, A. M., Vowles, C. J., Anderson, N. E., Poe, S., & Eaton, K. A. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1054596 · Cited by 52

Long-term training induces a healthy inflammatory and endocrine emergent biomarker profile in elderly men

de Gonzalo‐Calvo, D., Fernández‐Garcia, B., de Luxán‐Delgado, B., Rodríguez‐González, S., Macia, M. G., Suárez, F. M., Solano, J. J., Rodríguez‐Colunga, M. J., & Coto‐Montes, A. M. (2011) · AGE · doi:10.1007/s11357-011-9266-9 · Cited by 49

microRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer’s Disease (AD)

Hill, J. M., & Lukiw, W. J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1734-7 · Cited by 48

Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice

Gutiérrez‐Orozco, F., Thomas‐Ahner, J. M., Berman-Booty, L. D., Galley, J. D., Chitchumroonchokchai, C., Mace, T. A., Suksamrarn, S., Bailey, M. T., Clinton, S. K., Lesinski, G. B., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300771 · Cited by 48

A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update

Alam, M., Alam, Q., Kamal, M., Abuzenadah, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660151 · Cited by 47

Apolipoprotein Serum Amyloid A in Alzheimer's Disease

Kindy, M. S., Yu, J., Guo, J., & Zhu, H. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-1303 · Cited by 44

Molecular detection of bacterial contamination in gnotobiotic rodent units

Packey, C. D., Shanahan, M. T., Manick, S., Bower, M., Ellermann, M., Tonkonogy, S. L., Carroll, I. M., & Sartor, R. B. (2013) · Gut Microbes · doi:10.4161/gmic.25824 · Cited by 43

Role of Stress, Depression, and Aging in Cognitive Decline and Alzheimer’s Disease

Daulatzai, M. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_350 · Cited by 42

Considering a new paradigm for Alzheimer's disease research

Langley, G. R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.013 · Cited by 42

The Role of Iron-Induced Fibrin in the Pathogenesis of Alzheimer’s Disease and the Protective Role of Magnesium

Lipiński, B., & Pretorius, E. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00735 · Cited by 39

MicroRNA (miRNA): Sequence and stability, viroid-like properties, and disease association in the CNS

Pogue, A. I., Hill, J. M., & Lukiw, W. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.03.042 · Cited by 39

Serum Amyloid A Differentially Activates Microglia and Astrocytes via the PI3K Pathway

Yu, Y., Liu, J., Li, S.-Q., Lei, P., & Ye, R. D. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130818 · Cited by 35

TREM2 signaling, miRNA-34a and the extinction of phagocytosis

Zhao, Y., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00131 · Cited by 33

Antibodies to Potato Virus Y Bind the Amyloid β Peptide

Friedland, R. P., Tedesco, J. M., Wilson, A. C., Atwood, C., Smith, M. A., Perry, G. L., & Zagorski, M. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802088200 · Cited by 28

Uptake and Dynamics of Infectious Prion Protein in the Intestine

Ano, Y., Sakudo, A., Nakayama, H., & Onodera, T. (2009) · Protein and Peptide Letters · doi:10.2174/092986609787601642 · Cited by 27

Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies

Dai, Y., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660134 · Cited by 26

miRNAs and viroids utilize common strategies in genetic signal transfer

Hill, J. M., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00010 · Cited by 25

A Human-Based Integrated Framework forAlzheimer’s Disease Research

Pistollato, F., Cavanaugh, S. E., & Chandrasekera, P. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150281 · Cited by 21

Modulation of fibrin assembly and polymerization by the ??-amyloid of Alzheimer??s disease

Merkle, D. L., Cheng, C.-H., Castellino, F., & Chibber, B. A. (1996) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199609000-00011 · Cited by 19

Cross-kingdom sequence similarities between human micro-RNAs and plant viruses

Rebolledo-Mendez, J. D., Vaishnav, R., Cooper, N., & Friedland, R. P. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.24951 · Cited by 19

From Gut to Brain: Bioencapsulated Therapeutic Protein Reduces Amyloid Load Upon Oral Delivery

Mäger, I., Roberts, T. C., Wood, M. J. A., & Andaloussi, S. E. (2014) · Molecular Therapy · doi:10.1038/mt.2014.13 · Cited by 19

Why nutraceuticals do not prevent or treat Alzheimer's disease

Fisher, A. E. O., & Naughton, D. P. (2005) · Nutrition Journal · doi:10.1186/1475-2891-4-14 · Cited by 13

Ubiquitin profile and amyloid enhancing factor activity in Alzheimer and ‘normal’ human brain extracts

Ali‐Khan, Z., Normand, J., Alizadeh-Khiavi, K., Robitaille, Y., & Chronopoulos, S. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90849-3 · Cited by 13

Immunohistochemical Examination of Peyer's Patches in Senescence-Accelerated Mice

Yoshioka, H., Takeda, T., Higuchi, K., Ohshio, G., Miyake, T., Sugiyama, T., & Kita, T. (1990) · Autoimmunity · doi:10.3109/08916939008998429 · Cited by 9

Intestinal uptake of amyloid beta protein through columnar epithelial cells in suckling mice.

Ano, Y., Nakayama, H., Sakudo, A., Sawano, Y., Tanokura, M., Itohara, S., & Onodera, T. (2009) · PubMed · doi:10.14670/hh-24.283 · Cited by 5

Role of dietary patterns in the prevention and regression of insulin resistance-related cancers

Pistollato, F. (2015) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-140024 · Cited by 4

Influence of diet on the gut microbiome and implications for human health

Singh, R. K., Chang, H.-W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., Abrouk, M., Farahnik, B., Nakamura, M., Zhu, T. H., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1175-y · Cited by 2,599

Gut microbiome alterations in Alzheimer’s disease

Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137

Human gut microbiota/microbiome in health and diseases: a review

Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294

The Human Gut Microbiome – A Potential Controller of Wellness and Disease

Kho, Z. Y., & Lal, S. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01835 · Cited by 1,180

The Gut Microbiota and Alzheimer’s Disease

Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852

The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship

Zerdan, M. B., Hebbo, E., Hijazi, A., Gemayel, M. E., Nasr, J., Nasr, D., Yaghi, M., Bouferraa, Y., & Nagarajan, A. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221227090125 · Cited by 22

Brain-Gut-Microbiota Axis in Alzheimer’s Disease

Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826

Nutrition, gut microbiota, and alzheimer’s disease

Romanenko, M., Kholin, V., Koliada, A., & Vaiserman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.712673 · Cited by 56

Exploring the effect of gut microbiome on Alzheimer's disease

Pourahmad, R., Saleki, K., Zare, M., Aram, C., Farsani, A. S., Banazadeh, M., & Tafakhori, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101776 · Cited by 20

The Gut Microbiota and Alzheimer’s Disease

Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852